Investor corner

Investor’s Corner

C-Care is listed on the Development and Enterprise Market (“DEM”) of the Stock Exchange of Mauritius Limited.

C-Care is a subsidiary of C-Care International whose main shareholders are CIEL, Proparco, IFC, IFHA-II and Kibo Fund II.

Turnover as at
30 June 2024

3,623

MUR M

Operating profit as at
30 June 2024

462

MUR M

Profit after TAX as at
30 June 2024

324

MUR M

Share price as at
30 June 2024

10.00

(RS) Per Ordinary Share

Dear Shareholders,

On behalf of the Board of Directors, it is with great pleasure that we are sharing with you an overview of C-Care (Mauritius) Ltd’s achievements for the year ended 30 June 2024.

C-Care achieved strong financial performance through strategic initiatives and key decisions, including the launch of the first cancer treatment facility in March 2024 and significant upgrades to C-Care Darné and C-Care Wellkin.

We addressed staff concerns, introduced training programs, and enhanced community involvement with free health services and screenings. Our continued partnerships with NGOs and environmental initiatives reflect our commitment to social responsibility.

Despite facing competition, skilled labor shortages, and inflationary pressures, we remain grateful to our patients, staff, partners, and shareholders for their unwavering support.

Guillaume Dalais, Chairperson

&

Hélène Échevin, CEO

IR Contact

Ludovic Faustin
Group Financial Controller

Email: [email protected]